Gordon Carmichael - 31 Oct 2023 Form 4 Insider Report for GYRE THERAPEUTICS, INC. (GYRE)

Role
Director
Signature
/s/ Ruoyu Chen, as attorney-in-fact for Gordon Carmichael
Issuer symbol
GYRE
Transactions as of
31 Oct 2023
Net transactions value
$0
Form type
4
Filing time
01 Nov 2023, 06:15:22 UTC
Previous filing
01 Nov 2023
Next filing
16 Aug 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CBIO Stock Option (Right to Buy) Award $0 +1,866 $0.000000 1,866 31 Oct 2023 Common Stock 1,866 $6.93 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1 These options vest as to one-third on each of the first, second and third anniversaries of October 31, 2023, subject to the Reporting Person's continued service to the Issuer through each vesting date.